Non-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future Prospects
Recent advances in molecular genetic technologies have facilitated non-invasive prenatal testing (NIPT) through the analysis of cell-free fetal DNA in maternal plasma. NIPT can be used to identify monogenic disorders including the identification of autosomal recessive disorders where the maternally...
Main Author: | Peter Benn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | http://www.mdpi.com/2077-0383/3/2/537 |
Similar Items
-
Cell-free fetal DNA testing and its correlation with prenatal indications
by: Jing-wei Wang, et al.
Published: (2021-08-01) -
Prenatal Diagnosis of Chromosome Abnormalities: A 13-Year Institution Experience
by: Carmen Comas, et al.
Published: (2012-11-01) -
Validation of a Single-Nucleotide Polymorphism-Based Non-Invasive Prenatal Test in Twin Gestations: Determination of Zygosity, Individual Fetal Sex, and Fetal Aneuploidy
by: Errol R. Norwitz, et al.
Published: (2019-06-01) -
Efficiency of non-invasive prenatal screening in pregnant women at advanced maternal age
by: Hui Zhu, et al.
Published: (2021-01-01) -
False Low-Risk Single Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in Pentasomy 49,XXXXY
by: Manesha Putra, et al.
Published: (2018-01-01)